Beta-acetyldigoxin is a semi-synthetic derivative of Digoxin used to treat heart conditions like atrial fibrillation and heart failure. It works by inhibiting the sodium-potassium ATPase pump in heart cells, which increases calcium levels and strengthens cardiac contractions. In the body, it is converted into digoxin and offers more consistent absorption, but it must be used carefully due to the risk of toxicity.
BRAND NAMES
Beta-acetyldigoxin is marketed under brand names such as Novodigal, Acetigoxin, and Cardigoxin. These brands are used in the treatment of heart conditions like atrial fibrillation and heart failure, though availability may vary by country.
MECHANISM OF ACTION
Beta-acetyldigoxin works by inhibiting the sodium–potassium ATPase pump in heart cells, which increases calcium levels and strengthens heart contractions. This action improves heart efficiency and helps control abnormal heart rhythms.
PHARMACOKINETICS
Absorption
Beta-acetyldigoxin is well absorbed from the gut, with peak levels reached in 2–4 hours. Its absorption is more consistent than digoxin, and food has little effect on how it is absorbed.
Distribution
Beta-acetyldigoxin is widely distributed in body tissues, particularly in the heart, liver, kidneys, and skeletal muscles. It binds moderately to plasma proteins and can cross the placenta, allowing it to reach target organs effectively.
Metabolism
Beta-acetyldigoxin is partially metabolized in the liver, where it is converted into active digoxin. Some of the drug is also broken down by intestinal bacteria, while a portion remains unchanged and is excreted by the kidneys.
Excretion
Beta-acetyldigoxin is primarily excreted by the kidneys, mostly as unchanged drug. A small portion is eliminated through bile and feces. Its excretion rate can be affected by kidney function, so dose adjustments may be needed in patients with renal impairment.
PHARMACODYNAMICS
Beta-acetyldigoxin strengthens heart contractions, slows the heart rate, and reduces conduction through the AV node. These effects improve cardiac output and help control abnormal heart rhythms like atrial fibrillation.
ADMINISTRATION
Beta-acetyldigoxin is usually given orally in the form of tablets or capsules. It is taken at regular intervals as prescribed, with or without food, to maintain stable blood levels and ensure consistent therapeutic effects.
DOSAGE AND STRENGTH
Beta-acetyldigoxin is commonly available in oral tablets with strengths of 0.25 mg and 0.50 mg. The usual adult dose ranges from 0.25 mg to 1 mg per day, divided into one or more doses, depending on the patient’s condition, age, and kidney function. Dose adjustments are often needed in elderly patients or those with renal impairment.
FOOD INTERACTIONS
Beta-acetyldigoxin can be taken with or without food, as meals have little effect on its absorption. However, high intake of fiber, potassium, or magnesium may affect its action, so monitoring is advised.
DRUG INTERACTIONS
Beta-acetyldigoxin can interact with drugs like diuretics, amiodarone, verapamil, and quinidine, which may increase its levels and risk of toxicity. Medications that reduce absorption or increase clearance can lower its effectiveness, so careful monitoring is needed.
CONTRAINDICATIONS
Beta-acetyldigoxin should not be used in patients with ventricular fibrillation, severe heart block, myocarditis, or known hypersensitivity to digoxin. It is also unsafe in cases of significant electrolyte imbalances like low potassium or magnesium.
SIDE EFFECTS
Common side effects of beta-acetyldigoxin include nausea, vomiting, diarrhea, loss of appetite, fatigue, and dizziness. Cardiac-related effects such as arrhythmias, slow heart rate (bradycardia), or palpitations can also occur, especially if blood levels are too high. Visual disturbances like blurred or yellow vision may appear in some patients.
TOXICITY
Beta-acetyldigoxin toxicity can cause severe arrhythmias, slow heart rate, nausea, confusion, and visual disturbances. Low potassium or magnesium increases the risk, and medical treatment is needed if toxicity occurs.